title

Blood Bank Guy Essentials Podcast

Joe Chaffin, MD

3
Followers
3
Plays
Blood Bank Guy Essentials Podcast
Blood Bank Guy Essentials Podcast

Blood Bank Guy Essentials Podcast

Joe Chaffin, MD

3
Followers
3
Plays
OVERVIEWEPISODESYOU MAY ALSO LIKE

Details

About Us

Dr. Joe Chaffin from the "Blood Bank Guy" website takes his light-hearted approach to a biweekly interview show, discussing core transfusion medicine topics with educational leaders. You'll smile, and have fun, and never EVER stop learning!

Latest Episodes

077CE: Implementing Pathogen-reduced Platelets with Pat Kopko

Continuing education episode! On September 30, 2019, the United States Food and Drug Administration released the long awaited final guidance on bacterial risk control in platelets (see episode 076 for more details). One way that transfusion services can fulfill the recommendations in the guidance is to implement pathogen reduction technology.Dr. Pat Kopko and her team at the University of California-San Diego are well ahead of the curve, as they implemented PR-platelets in their hospital WAY back in 2017! Along the way, UCSD and their blood supplier (American Red Cross) had to answer many difficult questions and make many decisions (Why can't we just "flip a switch" and go from zero to 100% with PR-platelet supply? If we can't get to 100% right away, which patients get them first? And many more...). Pat joins me to describe lessons learned, with an eye toward where this all fits with the recent guidance.

52 MIN6 d ago
Comments
077CE: Implementing Pathogen-reduced Platelets with Pat Kopko

076: FDA Platelet Bacteria Guidance with Pat Kopko

Over the past several years, the United States Food and Drug Administration has considered many proposals for how to decrease the risk that a vulnerable patient would receive a platelet transfusion containing bacteria. On September 30, 2019, FDA released their "Final Guidance" with multiple recommendations that can appear confusing at first glance. This interview with Dr. Pat Kopko from UC-San Diego is designed to be a "first impression" tour through the options in the guidance. NOTE: Every facility should form their own impressions and determine their individual best course. I highly recommend focused conversations between blood suppliers and transfusion services to decide what is best in YOUR setting!

42 MIN1 w ago
Comments
076: FDA Platelet Bacteria Guidance with Pat Kopko

075CE: What About Fibrinogen? with Melissa Cushing

Continuing education episode!Are we ignoring the most important coag factor when transfusing bleeding patients? Melissa Cushing thinks the contribution of replacing critically low fibrinogen levels to survival of bleeding patients may be under-recognized. Shedescribes the current evidence for early fibrinogen replacement in the bleeding patient, logistical challenges transfusion services face, studies providing insights to desired fibrinogen target levels, and future options to provide early fibrinogen replacement with increased efficiency and safety.

57 MINAUG 14
Comments
075CE: What About Fibrinogen? with Melissa Cushing

074CE: Radioactive! with Chris Tormey

Continuing education episode! Transfusion-associated Graft-versus-Host Disease (TA-GVHD) is a notoriously deadly but thankfully rare transfusion complication. Blood banks have used irradiation of cellular blood products for decades to prevent TA-GVHD, but clinicians and laboratorians still sometimes misunderstand what irradiation does and does not do. Dr. Chris Tormey, co-author of a 2018 article in Archives of Pathology and Laboratory Medicine on this topic, is my guest on today's interview. Dr. Tormey details the past, present, and future of blood product irradiation in this practical and timely interview.

58 MINJUL 31
Comments
074CE: Radioactive! with Chris Tormey

073: Implementing Trauma Whole Blood with David Oh and Mike Goodman

More and more trauma surgeons are asking their hospitals when they can get low-titer, cold-stored, group O whole blood ("trauma whole blood"). This product, discussed in depth in episode 040CE, is one that comes with lots of choices, and Drs. David Oh and Mike Goodman from Hoxworth Blood Center and the University of Cincinnati led their hospital through those decisions. They join me to share their insights, lessons learned, and practical tips. Please note: This is not intended to be a recipe! Every facility must make their own decisions on how to implement trauma whole blood (if they do so at all!). This interview is meant to demonstrate how one facility successfully introduced the product, and what they learned while doing so.

56 MINJUL 10
Comments
073: Implementing Trauma Whole Blood with David Oh and Mike Goodman

072CE: Neonatal Platelet Transfusion with Martha Sola-Visner

Continuing education episode! For decades, neonates (especially in the United States) have been given platelet transfusions at considerably higher platelet counts than thresholds used in adults. New data suggests, however, that "less may be more" when it comes to transfusing platelets to these tiny and vulnerable patients! Dr. Martha Sola-Visner, a neonatologist from Boston, joins me to discuss the results of a recent large study that challenges our assumptions about neonatal platelet transfusion.

53 MINJUN 26
Comments
072CE: Neonatal Platelet Transfusion with Martha Sola-Visner

071: NEW Therapeutic Apheresis Guidelines with Nancy Dunbar

This month, the American Society for Apheresis (ASFA) released a new version of their epic document called “Guidelines on the Use of Therapeutic Apheresis in Clinical Practice” in the Journal of Clinical Apheresis.It is, in many ways,thestandard document that professionals in this field refer to when faced with a patient who may need treatment. One of the co-editors of the “Special Issue” (as it is also called), Dr. Nancy Dunbar, joins me to explain why you need to get your hands on the new guidelines right away!

43 MINJUN 19
Comments
071: NEW Therapeutic Apheresis Guidelines with Nancy Dunbar

070CE: Preventing Alloantibodies in Sickle Cell Disease with Stella Chou

Continuing education episode!Alloimmunization after red blood cell (RBC) transfusion is a huge challenge in the treatment of sickle cell disease (SCD). Even when donors and patients are matched using traditional serologic strategies, and even that matching includes blood from minority donors, anti-Rh antibodies in patients with sickle cell disease are formed way often than we would like or expect. Further, Dr. Stella Chou has shown that nearly a third of patients with those new antibodies actually have hemolytic transfusion reactions! It's a huge problem. In this interview, Stella Chou, a pediatric hematologist from Philadelphia, shares data she published in 2018 showing that the problem comes in part from widespread genetic RH variations in both African-American blood donors and patients with sickle cell disease. She models a future direction that may help us finally solve this problem once and for all: Genotype matching of donors and patients!

56 MINJUN 5
Comments
070CE: Preventing Alloantibodies in Sickle Cell Disease with Stella Chou

069CE: Preventing TRALI with Beth Shaz

Continuing education episode!Over the past 15 years, Transfusion-related Acute Lung Injury (TRALI) has caused in more deaths than any other complication. Since many cases are caused by antibodies in blood donors, blood collection establishments around the world have taken numerous steps in an effort to prevent TRALI (also known as TRALI "mitigation"). Dr. Beth Shaz and a group of distinguished researchers decided to investigate and see if they could quantify the impact of the interventions. They looked at over 10 million transfusions across 9 states in the U.S., and their results may surprise you!

43 MINMAY 22
Comments
069CE: Preventing TRALI with Beth Shaz

068: Transfusion in Cardiac Surgery with Pierre Tibi

Most blood bankers will tell you that cardiac surgery can lead to some of the most intense interactions between a transfusion service and an operating room. Over the decades, we have seen wide variations in how much blood surgeons transfuse, even among those practicing in the same hospital! Those times are changing, however. Dr. Pierre Tibi is a busy cardiac surgeon in Arizona who also happens to be a Patient Blood Management champion! Pierre joins me to pull back the curtain on what is really happening in the OR, and offers his thoughts on how we can all care best for our cardiac surgery patients (even those getting a "re-do!").

58 MINMAY 13
Comments
068: Transfusion in Cardiac Surgery with Pierre Tibi

Latest Episodes

077CE: Implementing Pathogen-reduced Platelets with Pat Kopko

Continuing education episode! On September 30, 2019, the United States Food and Drug Administration released the long awaited final guidance on bacterial risk control in platelets (see episode 076 for more details). One way that transfusion services can fulfill the recommendations in the guidance is to implement pathogen reduction technology.Dr. Pat Kopko and her team at the University of California-San Diego are well ahead of the curve, as they implemented PR-platelets in their hospital WAY back in 2017! Along the way, UCSD and their blood supplier (American Red Cross) had to answer many difficult questions and make many decisions (Why can't we just "flip a switch" and go from zero to 100% with PR-platelet supply? If we can't get to 100% right away, which patients get them first? And many more...). Pat joins me to describe lessons learned, with an eye toward where this all fits with the recent guidance.

52 MIN6 d ago
Comments
077CE: Implementing Pathogen-reduced Platelets with Pat Kopko

076: FDA Platelet Bacteria Guidance with Pat Kopko

Over the past several years, the United States Food and Drug Administration has considered many proposals for how to decrease the risk that a vulnerable patient would receive a platelet transfusion containing bacteria. On September 30, 2019, FDA released their "Final Guidance" with multiple recommendations that can appear confusing at first glance. This interview with Dr. Pat Kopko from UC-San Diego is designed to be a "first impression" tour through the options in the guidance. NOTE: Every facility should form their own impressions and determine their individual best course. I highly recommend focused conversations between blood suppliers and transfusion services to decide what is best in YOUR setting!

42 MIN1 w ago
Comments
076: FDA Platelet Bacteria Guidance with Pat Kopko

075CE: What About Fibrinogen? with Melissa Cushing

Continuing education episode!Are we ignoring the most important coag factor when transfusing bleeding patients? Melissa Cushing thinks the contribution of replacing critically low fibrinogen levels to survival of bleeding patients may be under-recognized. Shedescribes the current evidence for early fibrinogen replacement in the bleeding patient, logistical challenges transfusion services face, studies providing insights to desired fibrinogen target levels, and future options to provide early fibrinogen replacement with increased efficiency and safety.

57 MINAUG 14
Comments
075CE: What About Fibrinogen? with Melissa Cushing

074CE: Radioactive! with Chris Tormey

Continuing education episode! Transfusion-associated Graft-versus-Host Disease (TA-GVHD) is a notoriously deadly but thankfully rare transfusion complication. Blood banks have used irradiation of cellular blood products for decades to prevent TA-GVHD, but clinicians and laboratorians still sometimes misunderstand what irradiation does and does not do. Dr. Chris Tormey, co-author of a 2018 article in Archives of Pathology and Laboratory Medicine on this topic, is my guest on today's interview. Dr. Tormey details the past, present, and future of blood product irradiation in this practical and timely interview.

58 MINJUL 31
Comments
074CE: Radioactive! with Chris Tormey

073: Implementing Trauma Whole Blood with David Oh and Mike Goodman

More and more trauma surgeons are asking their hospitals when they can get low-titer, cold-stored, group O whole blood ("trauma whole blood"). This product, discussed in depth in episode 040CE, is one that comes with lots of choices, and Drs. David Oh and Mike Goodman from Hoxworth Blood Center and the University of Cincinnati led their hospital through those decisions. They join me to share their insights, lessons learned, and practical tips. Please note: This is not intended to be a recipe! Every facility must make their own decisions on how to implement trauma whole blood (if they do so at all!). This interview is meant to demonstrate how one facility successfully introduced the product, and what they learned while doing so.

56 MINJUL 10
Comments
073: Implementing Trauma Whole Blood with David Oh and Mike Goodman

072CE: Neonatal Platelet Transfusion with Martha Sola-Visner

Continuing education episode! For decades, neonates (especially in the United States) have been given platelet transfusions at considerably higher platelet counts than thresholds used in adults. New data suggests, however, that "less may be more" when it comes to transfusing platelets to these tiny and vulnerable patients! Dr. Martha Sola-Visner, a neonatologist from Boston, joins me to discuss the results of a recent large study that challenges our assumptions about neonatal platelet transfusion.

53 MINJUN 26
Comments
072CE: Neonatal Platelet Transfusion with Martha Sola-Visner

071: NEW Therapeutic Apheresis Guidelines with Nancy Dunbar

This month, the American Society for Apheresis (ASFA) released a new version of their epic document called “Guidelines on the Use of Therapeutic Apheresis in Clinical Practice” in the Journal of Clinical Apheresis.It is, in many ways,thestandard document that professionals in this field refer to when faced with a patient who may need treatment. One of the co-editors of the “Special Issue” (as it is also called), Dr. Nancy Dunbar, joins me to explain why you need to get your hands on the new guidelines right away!

43 MINJUN 19
Comments
071: NEW Therapeutic Apheresis Guidelines with Nancy Dunbar

070CE: Preventing Alloantibodies in Sickle Cell Disease with Stella Chou

Continuing education episode!Alloimmunization after red blood cell (RBC) transfusion is a huge challenge in the treatment of sickle cell disease (SCD). Even when donors and patients are matched using traditional serologic strategies, and even that matching includes blood from minority donors, anti-Rh antibodies in patients with sickle cell disease are formed way often than we would like or expect. Further, Dr. Stella Chou has shown that nearly a third of patients with those new antibodies actually have hemolytic transfusion reactions! It's a huge problem. In this interview, Stella Chou, a pediatric hematologist from Philadelphia, shares data she published in 2018 showing that the problem comes in part from widespread genetic RH variations in both African-American blood donors and patients with sickle cell disease. She models a future direction that may help us finally solve this problem once and for all: Genotype matching of donors and patients!

56 MINJUN 5
Comments
070CE: Preventing Alloantibodies in Sickle Cell Disease with Stella Chou

069CE: Preventing TRALI with Beth Shaz

Continuing education episode!Over the past 15 years, Transfusion-related Acute Lung Injury (TRALI) has caused in more deaths than any other complication. Since many cases are caused by antibodies in blood donors, blood collection establishments around the world have taken numerous steps in an effort to prevent TRALI (also known as TRALI "mitigation"). Dr. Beth Shaz and a group of distinguished researchers decided to investigate and see if they could quantify the impact of the interventions. They looked at over 10 million transfusions across 9 states in the U.S., and their results may surprise you!

43 MINMAY 22
Comments
069CE: Preventing TRALI with Beth Shaz

068: Transfusion in Cardiac Surgery with Pierre Tibi

Most blood bankers will tell you that cardiac surgery can lead to some of the most intense interactions between a transfusion service and an operating room. Over the decades, we have seen wide variations in how much blood surgeons transfuse, even among those practicing in the same hospital! Those times are changing, however. Dr. Pierre Tibi is a busy cardiac surgeon in Arizona who also happens to be a Patient Blood Management champion! Pierre joins me to pull back the curtain on what is really happening in the OR, and offers his thoughts on how we can all care best for our cardiac surgery patients (even those getting a "re-do!").

58 MINMAY 13
Comments
068: Transfusion in Cardiac Surgery with Pierre Tibi